System Formulary Update
Belantamab Mafodotin-blmf (Blenrep)
Situation
Belantamab mafodotin (Blenrep) 100 mg for injection was approved for addition to the health system formulary at the January 2021 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Belantamab mafodotin 100 mg for injection
Assessment/Recommendation
Change effective: Tuesday, March 2, 2021
System P&T voted to include the following products on the UNC Health Medication Formulary:
Note: Stock of this formulary product may vary at individual entities